Clinical Notes AI's AI-powered platform uses over 25 ... CNAI outputs align with insurance and reimbursement requirements to document progress throughout the behavioral health journey.

In this video, Kelsey Jakee speaks with industry leaders about how clinical innovators can maintain momentum when it comes to building progress in clinical trials. PA clinical development expert, ...

The company began by using AI to turn terabytes of information into 150-word synopses of patient histories, updated every two ...

highlighting progress in their clinical study on Non-Small Cell Lung Cancer with STK11 mutations. The company’s focus on developing its lead candidate, bemcentinib, positions it as a significant ...

There are two, you know. Two magic words. The first is “please.” The second, “thank you,” is my favorite. You’re right, “thank you” is actually two words right there, but you probably get it. Growing ...

Tyra Bioscience, Inc ( (TYRA)) has released its Q3 earnings. Here is a breakdown of the information Tyra Bioscience, Inc presented to its investors. Tyra Biosciences, Inc. is a clinical-stage ...

To get access to ad-free episodes, exclusive podcasts, unlimited briefings, stories, and transcripts, and other valuable bonus features sign up today.

The best universities for clinical medicine have shown strength in producing research related to a variety of medical and biomedical topics. These include anesthesia, cardiology, general and ...

Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment ...

presented to its investors. Acrivon Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing precision oncology medicines using its proprietary Acrivon ...

Ritu Baral has given her Buy rating due to a combination of factors, including the promising progress in Tenaya Therapeutics’ clinical trials and strong financial positioning. The company’s ...